Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-23T22:15:05.771Z Has data issue: false hasContentIssue false
  • English
  • Français

The 100 most cited manuscripts in head and neck cancer: a bibliometric analysis

Published online by Cambridge University Press:  31 October 2019

T S M Chu ,
H T Kwok ,
J Chan  and
F Y F Tse
T S M Chu*
Affiliation:
School of Medical Education, Newcastle University, Newcastle upon Tyne, UK
H T Kwok
Affiliation:
Leicester Medical School, University of Leicester, UK
J Chan
Affiliation:
Department of Cardiothoracic Surgery, Morriston Hospital, Swansea, Wales, UK
F Y F Tse
Affiliation:
Faculty of Medicine, Imperial College London, UK
*
Author for correspondence: Mr Timothy Shun Man Chu, School of Medical Education, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK E-mail: T.Chu1@newcastle.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

This study aimed to highlight the key studies that have led to the current understanding and treatment of head and neck cancer.

Method

The Thomson Reuters Web of Science database was used to identify relevant manuscripts. The results were ranked according to the number of citations. The 100 most cited papers were analysed.

Results

A total of 63 538 eligible papers were returned. The median number of citations was 626. The most cited paper compared radiotherapy with and without cetuximab (3205 citations). The New England Journal of Medicine had the most citations (23 514), and the USA had the greatest number of publications (n = 66). The most common topics of publication were the treatment (n = 45) and basic science (n = 19) of head and neck cancer, followed by the role of human papillomavirus (n = 16).

Conclusion

This analysis highlighted key articles that influenced head and neck cancer research and treatment. It serves as a guide as to what makes a ‘citable’ paper in this field.

Keywords

Head And Neck CancerHead And Neck NeoplasmsSquamous Cell Carcinoma Of Head And NeckBibliometric AnalysisBibliometrics
Type
Review Articles
Information
The Journal of Laryngology & Otology , Volume 133 , Issue 11 , November 2019 , pp. 936 - 942
Copyright
Copyright © JLO (1984) Limited, 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Mr T S M Chu takes responsibility for the integrity of the content of the paper

References

1Jemal, A, Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90Google Scholar
2Argiris, A, Eng, C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 2003;114:15–60Google Scholar
3Chaturvedi, AK, Engels, EA, Pfeiffer, RM, Hernandez, BY, Xiao, W, Kim, E et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294–301Google Scholar
4Fenton, JE, Roy, D, Hughes, JP, Jones, AS. A century of citation classics in otolaryngology-head and neck surgery journals. J Laryngol Otol 2002;116:494–8Google Scholar
5Saunders, TFC, Rymer, BC, McNamara, KJ. A global bibliometric analysis of otolaryngology: head and neck surgery literature. Clin Otolaryngol 2017;42:1338–42Google Scholar
6Paladugu, R, Schein, M, Gardezi, S, Wise, L. One hundred citation classics in general surgical journals. World J Surg 2002;26:1099–105Google Scholar
7Ellul, T, Bullock, N, Abdelrahman, T, Powell, AG, Witherspoon, J, Lewis, WG. The 100 most cited manuscripts in emergency abdominal surgery: a bibliometric analysis. Int J Surg 2017;37:29–35Google Scholar
8Joyce, CW, Kelly, JC, Sugrue, C. A bibliometric analysis of the 100 most influential papers in burns. Burns 2014;40:30–7Google Scholar
9Chan, J, Mak, TLA, Chu, TSM, Hui, TLY, Kwan, LYA. The 100 most cited manuscripts in coronary artery bypass grafting. J Card Surg 2019;34:782–7Google Scholar
10Bonner, JA, Harari, PM, Giralt, J, Azarnia, N, Shin, DM, Cohen, RB et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567–78Google Scholar
11Ragin, CC, Taioli, E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121:1813–20Google Scholar
12Ang, KK, Harris, J, Wheeler, R, Weber, R, Rosenthal, DI, Nguyen-Tan, PF et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35Google Scholar
13Gillison, ML, Koch, WM, Capone, RB, Spafford, M, Westra, WH, Wu, L et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–20Google Scholar
14Henle, W, Henle, G, Ho, HC, Burtin, P, Cachin, Y, Clifford, P et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 1970;44:225–31Google Scholar
15Ferris, RL, Blumenschein, G Jr, Fayette, J, Guigay, J, Colevas, AD, Licitra, L et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 2016;375:1856–67Google Scholar
16Bonner, JA, Harari, PM, Giralt, J, Cohen, RB, Jones, CU, Sur, RK et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010;11:21–8Google Scholar
17Vermorken, JB, Mesia, R, Rivera, F, Remenar, E, Kawecki, A, Rottey, S et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116–27Google Scholar
18Vermorken, JB, Trigo, J, Hitt, R, Koralewski, P, Diaz-Rubio, E, Rolland, F et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007;25:2171–7Google Scholar
19Brizel, DM, Albers, ME, Fisher, SR, Scher, RL, Richtsmeier, WJ, Hars, V et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798–804Google Scholar
20Calais, G, Alfonsi, M, Bardet, E, Sire, C, Germain, T, Bergerot, P et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081–6Google Scholar
21Wendt, TG, Grabenbauer, GG, Rodel, CM, Thiel, HJ, Aydin, H, Rohloff, R et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318–24Google Scholar
22Califano, J, van der Riet, P, Westra, W, Nawroz, H, Clayman, G, Piantadosi, S et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488–92Google Scholar
23Nawroz, H, Koch, W, Anker, P, Stroun, M, Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996;2:1035–7Google Scholar
24Schipper, JH, Frixen, UH, Behrens, J, Unger, A, Jahnke, K, Birchmeier, W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991;51:6328–37Google Scholar
25Cohen, EE, Rosen, F, Stadler, WM, Recant, W, Stenson, K, Huo, D et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003;21:1980–7Google Scholar
26Soulieres, D, Senzer, NN, Vokes, EE, Hidalgo, M, Agarwala, SS, Siu, LL. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 2004;22:77–85Google Scholar
27Herrero, R, Castellsague, X, Pawlita, M, Lissowska, J, Kee, F, Balaram, P et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772–83Google Scholar
28Mork, J, Lie, AK, Glattre, E, Hallmans, G, Jellum, E, Koskela, P et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001;344:1125–31Google Scholar
29Fakhry, C, Westra, WH, Li, S, Cmelak, A, Ridge, JA, Pinto, H et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–9Google Scholar
30Seiwert, TY, Burtness, B, Mehra, R, Weiss, J, Berger, R, Eder, JP et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol 2016;17:956–65Google Scholar
31Chaturvedi, AK, Anderson, WF, Lortet-Tieulent, J, Curado, MP, Ferlay, J, Franceschi, S et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013;31:4550–9Google Scholar
32Sun, GH, Houlton, JJ, Moloci, NM, MacEachern, MP, Bradford, CR, Prince, ME et al. Prospective head and neck cancer research: a four-decade bibliometric perspective. Oncologist 2013;18:584–9Google Scholar